DNA-daunorubicin complexes specifically suppress in vitro spontaneous anti-DNA antibody production in lymphocytes of patients with systemic lupus erythematosus
β Scribed by Tsutomu Takeuchi; Jun Koide; Osamu Hosono; Koichi Amano; Mitsuo Homma; Yasuhiko Masuho; Chikao Morimoto; Makoto Takano; Dr. Tohru Abe
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 716 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We examined the effect of DNase treatment of sera with antihistone activity. In non-systemic lupus erythematosus (SLE) sera, antihistone levels remained unmodified, but a significant decrease was observed in 7 of 11 SLE sera with anti-DNA antibodies. This was accompanied in some by an increase in an
To examine autoantibodies present in patients with active systemic lupus erythematosus (SLE), sera, circulating immune comptexes (CIC), and antibodies purified on DNA-immunoadsorbent were tested by enzyme immunoassay. A panel of self-antigens, including DNA, histones (HIS), glomerular basal membrane
Objective. To investigate whether antibodies to a T14 anti-DNA antibody can be found in patients with systemic lupus erythematosus (SLE). Methods. Seventy-six serum samples (37 from patients with SLE) were randomly selected from among sera submitted for routine antinuclear antibody testing. Short,